WAY Stock Analysis: Buy, Sell, or Hold?
WAY - Waystar Holding Corp. Common Stock
$23.74
-0.03 (-0.13%)
▼
5d:
-4.47%
30d:
-11.85%
90d:
-27.51%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Apr 29, 2026
26d
Smart Money Accumulation
WAY is down 8.8% this week, but smart money is accumulating calls. Top strike: $27.5 2026-04-17 with 162 OI. Call ratio: 87% View Scanner →
Strength: 8.1/10
Get Alerted When WAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: WAY trading at deep discount. Market pricing in -8.4% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: WAY trading at deep discount. Market pricing in -8.4% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$46.43
Based on 8.6% avg growth
INTRINSIC VALUE TODAY
$28.83
17.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: WAY is currently trading at $23.74, which is considered oversold relative to its 30-day fair value range of $23.91 to $25.80. From a valuation perspective, the stock is trading at a discount (Forward PE: 12.9) compared to its historical average (16.7). Remarkably, the market is currently pricing in an annual earnings decline of 8.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, WAY is in a strong downtrend. Immediate support is located at $22.85, while resistance sits at $25.17.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $36.39 (+53.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, WAY is in a strong downtrend. Immediate support is located at $22.85, while resistance sits at $25.17.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $36.39 (+53.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$23.91 -
$25.80
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 53.3% below Wall St target ($36.39)
Fair Price Analysis
30-Day Fair Range
$23.91 -
$25.80
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$22.85
Resistance Level
$25.17
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.87
Wall Street Target
$36.39
(+53.3%)
Revenue Growth (YoY)
24.3%
Earnings Growth (YoY)
-2.7%
Profit Margin
10.2%
Valuation Discount vs History
-8.4% cheaper
PE vs Historical
12.9 vs 16.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.4%
(market-implied from PE analysis)
1-Year Target
$21.75
(-8%)
2-Year Target
$19.92
(-16%)
3-Year Target
$18.25
(-23%)
3-Yr Target (if PE normalizes)
(PE: 13→17)
$23.68
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.6, Growth: 13.2%)
$55.10
(+132%)
Base:
(SPY PE: 12.9, Growth: 13.2%)
$34.47
(+45%)
Bear:
(PE: 10.9, Growth: 13.2%)
$29.30
(+23%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (39x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 39.49 | Current EPS (TTM): $0.61
Bull Case
$53.00
(+115%)
Analyst growth 100.0%, PE expands to 43.4
Base Case
$48.18
(+96%)
Market implied 100.0%, PE stable at 39.5
Bear Case
$16.38
(-34%)
Severe decline -20.0%, PE contracts to 33.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.9 to 16.7
Stabilization Target:
$30.80
(+29.8%)
PE Expansion Potential:
+29.8%
Share & Embed Analysis
Last updated: April 02, 2026 6:54 PM ET
Data refreshes hourly during market hours. Next update: 7:54 PM
Data refreshes hourly during market hours. Next update: 7:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WAY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Eric L (Ric) Sinclair III
SELL
40225 shares
2026-01-20
Eric L (Ric) Sinclair III
SELL
9701 shares
2025-12-22
Christopher L Schremser
SELL
8623 shares
2025-12-10
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$271 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 60 BUY |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 62 BUY |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$112 | 67 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$28 | 52 HOLD |
Advanced WAY Option Strategies
Professional options setups generated by AI based on today's WAY price and gamma walls.
